RE: What ...an RNS just landed24 Apr 2024 16:28
Result of Open Offer
London, UK - 29 September 2021: genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that it has conditionally raised total gross proceeds of approximately £1.1 million through the Open Offer which was announced on 10 September 2021.
Result of the Open Offer
The Company received valid acceptances for 4,450,852 Open Offer Shares which is less than the 18,091,442 Open Offer Shares that were offered to Qualifying Shareholders. As a result all subscriptions by Qualifying Shareholders will be met in full.
Therefore, the Company has raised total gross proceeds of approximately £7.1 million by way of the Placing and the Open Offer. Net proceeds are estimated to be approximately £6.6 million.
Application has been made to the London Stock Exchange for the admission of 28,450,852 New Ordinary Shares to trading on AIM ("Admission"). This comprises (i) 24,000,000 Placing Shares; and (ii) 4,450,852 Open Offer Shares. The New Ordinary Shares will rank pari passu with the existing Ordinary Shares.